Free Trial

Signature Estate & Investment Advisors LLC Invests $356,000 in Exelon Corporation $EXC

Exelon logo with Utilities background

Key Points

  • Signature Estate & Investment Advisors LLC made a new investment in Exelon Corporation, purchasing 7,722 shares valued at approximately $356,000.
  • Exelon reported $0.39 EPS for its last quarter, beating the consensus estimate of $0.37 and providing an FY 2025 guidance of 2.640-2.740 EPS.
  • The company declared a quarterly dividend of $0.40 per share, resulting in an annualized dividend yield of 3.7%.
  • Five stocks we like better than Exelon.

Signature Estate & Investment Advisors LLC bought a new position in shares of Exelon Corporation (NASDAQ:EXC - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 7,722 shares of the company's stock, valued at approximately $356,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Teza Capital Management LLC bought a new position in Exelon during the 1st quarter worth $546,000. Scientech Research LLC bought a new position in Exelon during the 1st quarter worth $1,072,000. Parallax Volatility Advisers L.P. bought a new position in Exelon during the 1st quarter worth $1,196,000. New England Asset Management Inc. increased its stake in Exelon by 0.6% during the 1st quarter. New England Asset Management Inc. now owns 120,915 shares of the company's stock worth $5,572,000 after acquiring an additional 760 shares during the period. Finally, Nissay Asset Management Corp Japan ADV increased its stake in Exelon by 10.2% during the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 248,245 shares of the company's stock worth $11,439,000 after acquiring an additional 22,894 shares during the period. Institutional investors own 80.92% of the company's stock.

Exelon Trading Up 0.5%

Shares of EXC opened at $43.32 on Thursday. Exelon Corporation has a 52-week low of $35.94 and a 52-week high of $48.11. The business's fifty day moving average is $44.00 and its 200-day moving average is $44.21. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95. The firm has a market cap of $43.75 billion, a price-to-earnings ratio of 16.47, a PEG ratio of 2.53 and a beta of 0.41.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.02. Exelon had a return on equity of 9.85% and a net margin of 11.16%.The company had revenue of $5.43 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the company posted $0.47 EPS. The company's revenue for the quarter was up 1.2% compared to the same quarter last year. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Equities analysts anticipate that Exelon Corporation will post 2.64 EPS for the current fiscal year.

Exelon Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Monday, August 11th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, August 11th. This represents a $1.60 annualized dividend and a dividend yield of 3.7%. Exelon's dividend payout ratio (DPR) is 60.84%.

Analyst Ratings Changes

A number of equities analysts have commented on EXC shares. UBS Group restated a "neutral" rating and set a $48.00 price objective (up previously from $47.00) on shares of Exelon in a research note on Friday, July 11th. KeyCorp lowered their price objective on Exelon from $39.00 to $37.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 16th. Finally, Morgan Stanley reiterated an "outperform" rating on shares of Exelon in a research note on Thursday, August 21st. Five investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Exelon currently has an average rating of "Hold" and an average price target of $47.20.

Check Out Our Latest Research Report on EXC

Exelon Company Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Further Reading

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXC - Free Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.